Fujitsu develops AI agent platform for healthcare sector

Fujitsu announced the development of a secure Artificial Intelligence (AI) agent platform aimed at enhancing operational efficiency in Japan's healthcare sector. The new platform features an orchestrator AI agent, which centralizes coordination among various specialized healthcare agents created by Fujitsu and its partners. This initiative focuses on implementing advanced medical operational practices to improve sustainability and streamline processes in the healthcare industry.

In 2025, Fujitsu plans to advance the commercialization of the platform in collaboration with medical institutions globally. This phase will involve validating the effectiveness of the healthcare orchestrator AI agent while also developing AI agents tailored for specific healthcare applications.

Under its Fujitsu Uvance business model, the company will continue its efforts to transform healthcare, aiming for personalized treatment solutions. This model aligns with the goal of enhancing individual well-being through data and AI.

The AI agent platform will offer a range of task-specific agents to support medical workflows, integrating various AI capabilities for data management and interoperability. This holistic system is designed to facilitate rapid transformation of medical operations while ensuring effective collaboration among AI agents.

Fujitsu intends to leverage its extensive knowledge of medical information systems combined with NVIDIA's agentic AI technology to support the application of leading medical operational standards.